248 related articles for article (PubMed ID: 28478442)
1. Thrombogenesis in Thrombophilic Pregnancy: Evaluation of Low-Molecular-Weight Heparin Prophylaxis.
Simeone R; Giacomello R; Bruno G; Parco S; Maximova N; Martinelli M; Zito G; Luppi S; Cervi G; Ricci G
Acta Haematol; 2017; 137(4):201-206. PubMed ID: 28478442
[TBL] [Abstract][Full Text] [Related]
2. The impact of dalteparin (Fragmin) on thrombin generation in pregnant women with venous thromboembolism: significance of the factor V Leiden mutation.
Schambeck CM; Eberl E; Geisen U; Grossmann R; Keller F
Thromb Haemost; 2001 May; 85(5):782-6. PubMed ID: 11372668
[TBL] [Abstract][Full Text] [Related]
3. Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss.
Sarig G; Blumenfeld Z; Leiba R; Lanir N; Brenner B
Thromb Haemost; 2005 Nov; 94(5):980-5. PubMed ID: 16363240
[TBL] [Abstract][Full Text] [Related]
4. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
[TBL] [Abstract][Full Text] [Related]
5. Thrombin generation and low-molecular-weight heparin prophylaxis in pregnant women with thrombophilia.
Selmeczi A; Roach RE; Móré C; Batta Z; Hársfalvi J; van der Bom JG; Boda Z; Oláh Z
Thromb Haemost; 2015 Feb; 113(2):283-9. PubMed ID: 25392852
[TBL] [Abstract][Full Text] [Related]
6. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
[TBL] [Abstract][Full Text] [Related]
7. [Monitoring of low-molecular-weight heparins in pregnant women with inherited thrombophilic disorders].
Paskaleva I; Karagiozova Zh; Doncheva E; Dineva D
Akush Ginekol (Sofiia); 2014; 53(2):3-10. PubMed ID: 25098102
[TBL] [Abstract][Full Text] [Related]
8. [Thrombophilia, anticoagulant therapy and pregnancy].
Boda Z; László P; Pfliegler G; Tornai I; Rejtö L; Schlammadinger A
Orv Hetil; 1998 Dec; 139(52):3113-6. PubMed ID: 9914731
[TBL] [Abstract][Full Text] [Related]
9. Does anticoagulant therapy improve pregnancy outcome equally, regardless of specific thrombophilia type?
Kovac M; Mikovic Z; Mitic G; Djordjevic V; Mandic V; Rakicevic L; Radojkovic D
Clin Appl Thromb Hemost; 2014 Mar; 20(2):184-9. PubMed ID: 23262970
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation assay identifies individual variability in responses to low molecular weight heparin in pregnancy: implications for anticoagulant monitoring.
Chowdary P; Adamidou D; Riddell A; Aghighi S; Griffioen A; Priest P; Moghadam L; Kelaher N; Huq FY; Kadir RA; Tuddenham EG; Gatt A
Br J Haematol; 2015 Mar; 168(5):719-27. PubMed ID: 25351814
[TBL] [Abstract][Full Text] [Related]
11. Thromboprophylaxis implementation during pregnancy in women with recurrent foetal losses and thrombophilia.
Mitić G; Novakov Mikić A; Povazan L; Mitreski A; Kopitović V; Vejnović T
Med Pregl; 2011; 64(9-10):471-5. PubMed ID: 22097113
[TBL] [Abstract][Full Text] [Related]
12. The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, treatment in pregnant women with previous thromboembolism.
Antovic A; Blombäck M; Bremme K; He S
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):181-6. PubMed ID: 11943930
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an optimal dose of low-molecular-weight heparin for thromboprophylaxis in pregnant women at risk of thrombosis using coagulation activation markers.
Bombeli T; Raddatz Mueller P; Fehr J
Haemostasis; 2001; 31(2):90-8. PubMed ID: 11684864
[TBL] [Abstract][Full Text] [Related]
14. Assessment and management of high-risk pregnancies in women with thrombophilia.
Sarig G; Vidergor G; Brenner B
Blood Rev; 2009 Jul; 23(4):143-7. PubMed ID: 19135285
[TBL] [Abstract][Full Text] [Related]
15. [Thrombophilia, preeclampsia and other pregnancy complications].
Vucić N; Frleta M; Petrović D; Ostojić V
Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulant therapy and thromboprophylaxis in patients with thrombophilia.
Weintraub AY; Sheiner E
Arch Gynecol Obstet; 2007 Dec; 276(6):567-71. PubMed ID: 17828548
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of low molecular weight heparin in pregnancy.
Shiach CR
Hematology; 2003 Feb; 8(1):47-52. PubMed ID: 12623427
[No Abstract] [Full Text] [Related]
18. Prospective evaluation of coagulation activation in pregnant women receiving low-molecular weight heparin.
Hoke M; Kyrle PA; Philipp K; Pabinger I; Kaider A; Schönauer V; Quehenberger P; Eichinger S
Thromb Haemost; 2004 May; 91(5):935-40. PubMed ID: 15116254
[TBL] [Abstract][Full Text] [Related]
19. Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study.
Kosar A; Kasapoglu B; Kalyoncu S; Turan H; Balcik OS; Gümüs EI
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):14-8. PubMed ID: 21042205
[TBL] [Abstract][Full Text] [Related]
20. ProCGlobal and endogenous thrombin potential during pregnancy.
Hron G; Kyrle PA; Kaider A; Philipp K; Pabinger I; Kollars M; Eichinger S
Am J Obstet Gynecol; 2010 Nov; 203(5):463.e1-6. PubMed ID: 20598285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
